Table 2.
Anaplastic grade | Sample | HRPF | Distant metastasis | Secondary tumors | RB1 mutation | Laterality | Age at diagnosis (months) | Follow-up period (months) |
---|---|---|---|---|---|---|---|---|
Mild | RB 3 | No | No | No | ND | Bilateral | 3 | 120 |
RB 5 | Postlaminar ON | No | Pinealoma | G | Bilateral | 1 | 56 | |
RB 6 | No | No | No | ND | Bilateral | 2 | 69 | |
RB 7 | Postlaminar ON, massive choroidal invasion | No | No | G | Bilateral | 1 | 10 | |
RB 19 | No | No | No | ND | Unilateral | 11 | 81 | |
RB 23 | No | No | No | NG | Unilateral | 17 | 42 | |
Moderate | RB 1 | No | No | RCC | ND | Bilateral | 3 | 212 |
RB 2 | No | No | No | ND | Bilateral | 10 | 179 | |
RB 4 | No | No | No | ND | Bilateral | 4 | 186 | |
RB 8 | No | No | No | G | Bilateral | 4 | 141 | |
RB 9 | No | No | No | G | Unilateral | 11 | 96 | |
RB 11 | Postlaminar ON | No | No | ND | Unilateral | 4 | 71 | |
RB 14 | Postlaminar ON, massive choroidal invasion | Brain | No | ND | Unilateral | 28 | 22 | |
RB 16 | Massive choroidal invasion | Bone | No | ND | Unilateral | 24 | 140 | |
RB 17 | No | No | No | G | Unilateral | 21 | 76 | |
RB 18 | No | No | No | NG | Unilateral | 2 | 91 | |
RB 22 | No | No | No | NG | Unilateral | 11 | 16 | |
RB 26 | No | No | No | ND | Bilateral | 26 | 138 | |
RB 31 | No | No | No | None | Unilateral | 23 | 64 | |
Severe | RB 12 | Postlaminar ON | No | No | ND | Unilateral | 18 | 45 |
RB 13 | Postlaminar ON, massive choroidal invasion | No | No | G | Unilateral | 27 | 78 | |
RB 21 | Postlaminar ON, massive choroidal invasion | No | No | NG | Unilateral | 34 | 35 | |
RB 24 | No | Bone, Liver | No | NG | Unilateral | 19 | 19 | |
RB 25 | No | No | No | NG | Unilateral | 28 | 40 | |
RB 28 | Laminar ON, nonmassive choroidal invasion | No | No | NG | Unilateral | 46 | 58 | |
RB 30 | No | Liver, Bone marrow | No | NG | Unilateral | 27 | 9 | |
RB 32 | No | No | No | NG | Unilateral | 54 | 43 | |
RB 33 | Massive choroidal invasion | No | No | NG | Unilateral | 37 | 12 |
G, germline; ND, not determined; NG, nongermline; ON, optic nerve invasion; RB, retinoblastoma; RCC, renal cell carcinoma.